Injection device
AssigneeJCR Pharmaceuticals Co., Ltd.
InventorsHiroshi Matsumto, Masahiro Urakami, Noriyuki Tanaka, Yoshitaka Yamashita, Shinji Kotani, Takashi Hanada, Masafumi Tatsumi
Life of this patent
Estimating the term…
Loading patent…
AssigneeJCR Pharmaceuticals Co., Ltd.
InventorsHiroshi Matsumto, Masahiro Urakami, Noriyuki Tanaka, Yoshitaka Yamashita, Shinji Kotani, Takashi Hanada, Masafumi Tatsumi
Estimating the term…
Disclosed is an injection device for properly dissolving pharmaceutical agents contained in a two-compartment syringe having slidable front and rear walls, and then performing portionwise multiple injections. The injection device comprises a front casing designed to enclose and hold the two-compartment syringe with a double-ended needle attached to the front end of it, a rear casing designed to receive the thus held two-compartment syringe being inserted in the rear-end first manner, and to lock and hold the front casing, a piston rod placed in the rear casing and designed to push from behind and carry forward the slidable rear wall, wherein the piston rod can be pushed forwardly from behind the rear casing, and a spring provided so that, when the front end of the piston rod is moved backward, the spring may be once compressed and then push the piston rod to a forward position again, and forwardly drives the slidable rear wall to abut on the slidable front wall.
An injection device for receiving a two-compartment syringe having a front end quipped with a septum that can be pierced by a double-ended needle, a cylindrical side wall, a slidable front wall and a slidable rear wall that are liquid-tightly and slidably fitted in the side wall, and a bypass which is defined in the internal surface of the side wall between the front end and the slidable front wall and has a longitudinal length sufficient to stride the thickness of the slidable front wall, the two-compartment syringe containing a first pharmaceutical component in the front space defined between the front end and the slidable front wall and a second, liquid pharmaceutical component in the rear space defined between the slidable front wall and the slidable rear wall;
Dependencies are inferred from the claim text.